文献速递关节外科

前瞻性单中心随机对照研究比较250例后稳定型全膝关节置换术中髌骨置换与非置换至少五年随访

A Prospective, Single-Center, Randomized Controlled Study Comparing Non-Resurfacing versus Resurfacing in a Cohort of 250 Posterior-Stabilized Total Knee Arthroplasty With a Minimum Five-Year Follow-Up.
PubMed 文献 · J Arthroplasty · 2025-10-04

这项单中心前瞻性随机试验纳入2017年4月至2018年11月间行初次全膝关节置换术的250膝(245例),随机分为髌骨置换组与非置换组,均使用同一后稳定型「髌骨友好」假体。至少5年随访时两组临床评分无显著差异,髌骨置换组因髌股原因翻修率为3.8%且组间无显著差异,植入物生存率相似。作者认为常规髌骨置换无临床优势,支持基于客观标准的选择性置换策略。

要点

  • 5年随访时髌骨置换组与非置换组KSS膝关节评分(P=0.10)、KSS功能评分(P=0.19)、遗忘关节评分(P=0.24)、Kujala评分(P=0.36)和Lille评分(P=0.43)均无显著差异。
  • 非置换组5例(4.5%)需二次髌骨置换,置换组2例(1.8%)需髌骨假体翻修,髌股原因翻修率3.8%且组间无显著差异(P=0.16)。
  • 60个月时髌骨置换组与非置换组植入物生存率相似(93.6%对91.8%,P=0.96)。

核心结论

  • 这项大型前瞻性随机研究发现,5年随访时常规髌骨置换无临床优势。
  • 作者认为髌骨置换可能减少膝前痛,但也带来骨折和轨迹不良等风险。
  • 在后稳定型「髌骨友好」假体背景下,作者认为这些发现支持更选择性的方法,应由客观标准指导。

研究设计与样本

  • 单中心前瞻性随机对照试验,纳入2017年4月至2018年11月间行初次全膝关节置换术的250膝(245例)。
  • 排除标准为孤立性髌股骨关节炎、限制性全膝关节置换术和术前屈曲小于90度。
  • 患者随机分为髌骨置换组与髌骨非置换组,均接受同一后稳定型「髌骨友好」假体。

主要发现

  • 5年随访时213膝(髌骨置换组109膝、非置换组104膝) available,失访9%、死亡4%。
  • 临床结局组间无显著差异:KSS膝关节评分P=0.10;KSS功能评分P=0.19;遗忘关节评分P=0.24;Kujala评分P=0.36;Lille评分P=0.43。
  • 非置换组5例(4.5%)需二次髌骨置换,髌骨置换组2例(1.8%)需髌骨假体翻修。
  • 髌股原因翻修率为3.8%,组间无显著差异(P=0.16)。
  • 60个月时髌骨置换组与非置换组植入物生存率相似(93.6%对91.8%,P=0.96)。

关键数值与推荐

  • 5年随访KSS膝关节评分P=0.10,组间无显著差异。
  • 5年随访KSS功能评分P=0.19,组间无显著差异。
  • 5年随访遗忘关节评分P=0.24,组间无显著差异。
  • 5年随访Kujala评分P=0.36、Lille评分P=0.43,组间无显著差异。
  • 髌股原因翻修率3.8%,组间无显著差异(P=0.16);60个月植入物生存率髌骨置换组93.6%对非置换组91.8%(P=0.96)。

临床怎么用

  • 作者认为在后稳定型「髌骨友好」假体背景下,这些发现支持更选择性的方法,应由客观标准指导。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite extensive research, patellar management during total knee arthroplasty (TKA) remains controversial. We therefore asked the following: Is there a difference in clinical and radiological outcomes at a minimum 5-year follow-up with a modern posterior-stabilized TKA performed with or without patellar resurfacing (PR)? MATERIALS AND METHODS: This single-center prospective randomized trial included 250 knees (245 patients) undergoing primary TKA between April 2017 and November 2018. Exclusion criteria were isolated patellofemoral osteoarthritis, constrained TKA, and preoperative flexion less than 90°. Patients were randomized into PR or patellar nonresurfacing (PNR) groups, receiving the same posterior-stabilized "patella-friendly" prosthesis. Clinical evaluation at 5-year follow-up included the Knee Society Score (KSS), Forgotten Joint Score, Kujala and Lille scores for anterior knee pain, and range of motion. Radiographic assessment evaluated patellofemoral osteoarthritis progression and patellar implant loosening. Complications and surgical revisions were recorded. RESULTS: There were 213 knees (109 in PR, 104 in PNR) available with a 5-year follow-up (9% lost to follow-up and 4% deceased). Clinical outcomes showed no significant differences between groups (KSS knee: P = 0.10; KSS function: P = 0.19; Forgotten Joint Score: P = 0.24; Kujala: P = 0.36; Lille: P = 0.43). There were five patients (4.5%) in PNR who required secondary PR, whereas two patients (1.8%) in PR required revision of the patellar button. The revision rate for patellofemoral causes was 3.8%, without significant difference between groups (P = 0.16). At 60 months, implant survival was similar between PR and PNR (93.6 and 91.8%; P = 0.96). CONCLUSION: This large prospective randomized study found no clinical advantage of routine PR at 5-year follow-up. While resurfacing may reduce anterior knee pain, it also introduces risks such as fracture and maltracking. In the context of patella-friendly posterior-stabilized implants, these findings support a more selective approach, which should be guided by objective criteria.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Catteeuw A, Vermue H, Lefeuvre A, et al. A Prospective, Single-Center, Randomized Controlled Study Comparing Non-Resurfacing versus Resurfacing in a Cohort of 250 Posterior-Stabilized Total Knee Arthroplasty With a Minimum Five-Year Follow-Up. J Arthroplasty. 2025. PMID: 41052730. doi:10.1016/j.arth.2025.09.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。